Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 174 (TMEM174) is a protein-coding gene highly expressed in the kidney and localized to the apical plasma membrane of renal proximal tubular cells[1][4]. TMEM174 functions as a regulator of phosphate ion homeostasis by modulating the sodium-phosphate cotransporter SLC34A1 (NaPi2a), with its activity influenced by parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23)[1][3]. TMEM174 also enhances cell proliferation by activating the AP-1 transcription factor, partly through ERK signaling[2][3]. Elevated expression of TMEM174 is associated with certain renal cancers and may play a significant role in the development and progression of kidney cancer[2][3]. Currently, no drugs targeting TMEM174 are reported, and clinical utility as a biomarker or therapeutic target remains under investigation.
Not established for drugs due to lack of drug interactions; however, TMEM174 modulates phosphate reabsorption via interaction with NaPi2a and responds to phosphaturic hormones (PTH, FGF23)[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 174 (TMEM174).